A new anti-tumor cytotoxic triterpene from Ganoderma lucidum

Ganoderma lucidum (G. lucidum) is a famous medicinal fungus used as a traditional medicine for generations in China. Among bioactivities that G. lucidum possesses, the anti-tumor effect has aroused extensive interests. In this study, one new triterpene (1) was isolated from 90% ethanol extract of the dried fruiting bodies of G. lucidum. Its structure was determined based on the analysis of its spectroscopic data, including 1 D and 2 D NMR and MS spectra. Furthermore, 1 elicited moderate anti-tumor activities (IC50 values of 15.38 +/- 0.34 and 18.61 +/- 0.55 mu M for A549 and HepG2 cells, respectively) compared with cisplatin which was employed as the positive drug with IC50 values of 8.21 +/- 0.17 and 5.36 +/- 0.29 mu M for A549 and HepG2 cells, respectively. The mechanism study by RT-qPCR and western blot analysis suggested that the p53/caspase-3 pathway is involved in the 1-induced apoptosis.

Automated summary

Ganoderma lucidum, a traditional medicinal fungus in China, has been found to possess a new triterpene compound that shows moderate anti-tumor activities, possibly inducing apoptosis through the p53/caspase-3 pathway.